Sleep-disordered breathing and cardiovascular disease: still an open problem

Symposium
Chairs: S. Ryan (Dublin, Ireland), J. Pépin (Grenoble, France)
Aims: Results of studies on CPAP as secondary cardiovascular prevention in OSA patients have been discouraging. The frequent association of OSA with cardiovascular disease is clinically important, and will be re-examined in this session with special attention to the latest research.

Introduction S. Ryan (Dublin, Ireland), J. Pépin (Grenoble, France)
OSA and coronary artery disease Y. Peker (Istanbul, Turkey)
OSA and stroke R. Riha (Edinburgh (Edinburgh), United Kingdom)
OSA and atrial fibrillation C. Lombardi (Milano (MI), Italy)
Discussion and Q&A C. Lombardi (Milano (MI), Italy), R. Riha (Edinburgh (Edinburgh), United Kingdom), Y. Peker (Istanbul, Turkey), S. Ryan (Dublin, Ireland), J. Pépin (Grenoble, France)